Literature DB >> 1380771

The heart in Tangier disease. Severe coronary atherosclerosis with near absence of high-density lipoprotein cholesterol.

S L Mautner1, J A Sanchez, D J Rader, G C Mautner, V J Ferrans, D S Fredrickson, H B Brewer, W C Roberts.   

Abstract

Cardiac necropsy findings are described in a 72-year-old man with Tangier disease whose plasma total cholesterol levels averaged 70 mg/dL, low-density lipoprotein cholesterol level was 45 mg/dL, and high-density lipoprotein cholesterol level was 1.4 mg/dL, and who had coronary artery bypass grafting for severe atherosclerotic coronary artery disease. At necropsy, 24 of the 72 (33%) 5-mm segments of the 4 major (right, left main, left anterior descending, and left circumflex) native coronary arteries and 4 of the 27 (15%) 5-mm segments of the saphenous vein aortocoronary bypass conduits were narrowed by more than 75% in cross-sectional area by atherosclerotic plaques. The plaques were composed primarily (91% to 97%) of fibrous tissue. Oil red O staining, polarized light microscopy, and electron microscopy revealed cholesterol deposits in the plaques and in the walls of coronary arteries, saphenous vein grafts, and aorta. Such deposits also were found in foam cells of histiocytic origin, fibroblasts in all four cardiac valves, and in Schwann cells of cardiac nerves.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380771     DOI: 10.1093/ajcp/98.2.191

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Facts and ideas from anywhere.

Authors:  William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-01

2.  Clinical utility gene card for: Fabry disease - update 2016.

Authors:  Andreas Gal; Michael Beck; Wolfgang Höppner; Dominique P Germain
Journal:  Eur J Hum Genet       Date:  2017-03-22       Impact factor: 4.246

3.  Coronary artery bypass grafting for a patient with Tangier disease.

Authors:  Hiroshi Takami; Tohru Kobayashi; Tsutomu Nakagawa; Makoto Sakurai; Nobuhisa Awata; Shizuya Yamashita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-09

4.  The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency).

Authors:  A F Winder; R Alexander; A Garner; D Johnston; D Vallance; G McCreanor; J Frohlich
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

5.  Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.

Authors:  M Walter; H Reinecke; U Gerdes; J R Nofer; G Höbbel; U Seedorf; G Assmann
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.

Authors:  Andrew S Geller; Eliana Y Polisecki; Margaret R Diffenderfer; Bela F Asztalos; Sotirios K Karathanasis; Robert A Hegele; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2018-10-17       Impact factor: 5.922

Review 7.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

8.  Clinical utility gene card for: Tangier disease.

Authors:  Amanda J Hooper; Sally P A McCormick; Robert A Hegele; John R Burnett
Journal:  Eur J Hum Genet       Date:  2017-05-24       Impact factor: 4.246

9.  LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.

Authors:  Rhonda Flores; Xueting Jin; Janet Chang; Connie Zhang; David G Cogan; Ernst J Schaefer; Howard S Kruth
Journal:  Biomolecules       Date:  2019-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.